Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner - PubMed (original) (raw)
. 2010 Aug 15;185(4):2032-43.
doi: 10.4049/jimmunol.0903919. Epub 2010 Jul 19.
Affiliations
- PMID: 20644164
- DOI: 10.4049/jimmunol.0903919
Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner
Ageliki Tsagaratou et al. J Immunol. 2010.
Abstract
The cylindromatosis tumor suppressor gene (Cyld) encodes a deubiquitinating enzyme (CYLD) with immunoregulatory function. In this study, we evaluated the role of Cyld in T cell ontogeny by generating a mouse (Cyld(Delta9)) with a thymocyte-restricted Cyld mutation that causes a C-terminal truncation of the protein and reciprocates catalytically inactive human mutations. Mutant mice had dramatically reduced single positive thymocytes and a substantial loss of peripheral T cells. The analyses of polyclonal and TCR-restricted thymocyte populations possessing the mutation revealed a significant block in positive selection and an increased occurrence of apoptosis at the double-positive stage. Interestingly, in the context of MHC class I and II restricted TCR transgenes, lack of functional CYLD caused massive deletion of thymocytes that would have been positively selected, which is consistent with an impairment of positive selection. Biochemical analysis revealed that Cyld(Delta9) thymocytes exhibit abnormally elevated basal activity of NF-kappaB and JNK. Most importantly, inactivation of NF-kappaB essential modulator fully restored the NF-kappaB activity of Cyld(Delta9) thymocytes to physiologic levels and rescued their developmental and survival defect. This study identifies a fundamental role for functional CYLD in establishing the proper threshold of activation for thymocyte selection by a mechanism dependent on NF-kappaB essential modulator.
Similar articles
- Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A, Grammenoudi S, Mosialos G. Tsagaratou A, et al. Eur J Immunol. 2011 Oct;41(10):3054-62. doi: 10.1002/eji.201041160. Epub 2011 Aug 30. Eur J Immunol. 2011. PMID: 21728169 - The lack of NF-kappa B transactivation and PKC epsilon expression in CD4(+)CD8(+) thymocytes correlates with negative selection.
Simon AK, Auphan N, Pophillat M, Boyer C, Ghosh S, Rincón M, Flavell RA, Schmitt-Verhulst AM. Simon AK, et al. Cell Death Differ. 2000 Dec;7(12):1253-62. doi: 10.1038/sj.cdd.4400760. Cell Death Differ. 2000. PMID: 11175263 - Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection.
Costello PS, Nicolas RH, Watanabe Y, Rosewell I, Treisman R. Costello PS, et al. Nat Immunol. 2004 Mar;5(3):289-98. doi: 10.1038/ni1038. Epub 2004 Feb 8. Nat Immunol. 2004. PMID: 14770179 - CYLD: a multifunctional deubiquitinase.
Glittenberg M, Ligoxygakis P. Glittenberg M, et al. Fly (Austin). 2007 Nov-Dec;1(6):330-2. doi: 10.4161/fly.5399. Epub 2007 Nov 10. Fly (Austin). 2007. PMID: 18820455 Review. - CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC. Sun SC. Cell Death Differ. 2010 Jan;17(1):25-34. doi: 10.1038/cdd.2009.43. Cell Death Differ. 2010. PMID: 19373246 Free PMC article. Review.
Cited by
- Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity.
Huang X, Zhang X, Xu J, Wang X, Zhang G, Tang T, Shen X, Liang T, Bai X. Huang X, et al. Front Oncol. 2020 Aug 7;10:1289. doi: 10.3389/fonc.2020.01289. eCollection 2020. Front Oncol. 2020. PMID: 32850399 Free PMC article. Review. - Deubiquitinases in the regulation of NF-κB signaling.
Harhaj EW, Dixit VM. Harhaj EW, et al. Cell Res. 2011 Jan;21(1):22-39. doi: 10.1038/cr.2010.166. Epub 2010 Nov 30. Cell Res. 2011. PMID: 21119682 Free PMC article. Review. - Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report.
Karatzas DN, Xanthopoulos K, Kotantaki P, Pseftogas A, Teliousis K, Hatzivassiliou EG, Kontoyiannis DL, Poutahidis T, Mosialos G. Karatzas DN, et al. Cell Oncol (Dordr). 2016 Jun;39(3):287-93. doi: 10.1007/s13402-016-0279-3. Epub 2016 Apr 4. Cell Oncol (Dordr). 2016. PMID: 27042826 - The Function of Ubiquitination in T-Cell Development.
Peng Z, Zhang H, Hu H. Peng Z, et al. Adv Exp Med Biol. 2024;1466:135-159. doi: 10.1007/978-981-97-7288-9_10. Adv Exp Med Biol. 2024. PMID: 39546141 Review. - Mechanism study of ubiquitination in T cell development and autoimmune disease.
Yu H, Yang W, Cao M, Lei Q, Yuan R, Xu H, Cui Y, Chen X, Su X, Zhuo H, Lin L. Yu H, et al. Front Immunol. 2024 Mar 18;15:1359933. doi: 10.3389/fimmu.2024.1359933. eCollection 2024. Front Immunol. 2024. PMID: 38562929 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials